南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

阿特拉青诺尔III通过药理学促进p62介导的Keap1自噬降解,可缓解酒精诱导的肝损伤中肝脏脂肪变性和衰老现象。

Pharmacological promotion of p62-mediated Keap1 autophagic degradation by Atractylenolide III ameliorates hepatic steatosis and senescence in alcohol-induced liver injury

Shijie Dai, Yangsheng Wu, Mingjiang Mao, Shouye Li, Zheming Li, Lin Chen, Yu Dong, Ping Qiu, Xiaobing Dou, Xiaofeng Yuan

Journal:Journal of Pharmaceutical Analysis

IF:11.2

DOI:10.1016/j.jpha.2026.101791

PMID:

Published:2026-09-10

research field:氧化应激自噬信号通路肝脏病学分子药理学

Abstract

Alcoholic liver disease (ALD) is a chronic liver condition worldwide that is driven by an annual increase in alcohol consumption. This study aimed to investigate the impact of atractylenolide III (AT-III) in ALD. Male C57BL/6N mice fed an ethanol (EtOH)-containing liquid diet and EtOH-induced AML12 cells were used systematically to assess the effect of AT-III on liver injury using histological and biochemical assays. Additionally, the regulatory effect of AT-III on nuclear factor erythroid-2-related factor 2 (Nrf2) was validated in Nrf2 −/− mice. Molecular docking, cellular thermal shift assay (CETSA), surface plasmon resonance (SPR), quantitative real-time polymerase chain reaction (PCR), Western blotting, immunofluorescence, immunohistochemistry, and coimmunoprecipitation analyses were employed to demonstrate the effects of AT-III on ALD. This study found that AT-III could ameliorate biochemical and pathological liver injury in ALD mice. Moreover, AT-III inhibited oxidative stress and cellular senescence both in vivo and in vitro by activating the adenosine monophosphate (AMP)-activated protein kinase (AMPK)/Nrf2 pathway. Importantly, molecular docking, CETSA, and SPR analyses demonstrated that AT-III had a favorable binding ability with AMPK and that the AMPK inhibitor compound C (CC) or inhibition of Nrf2 markedly abolished the inhibitory effects of AT-III on lipid accumulation and cellular senescence in EtOH-induced AML12 cells and Nrf2 −/− mice. Mechanistically, AT-III promoted p62-dependent autophagic degradation of Kelch-like ECH-associated protein 1 (Keap1) and thereby induced Nrf2 translocation into the nucleus. In conclusion, the protective role of AT-III against EtOH-induced ALD was mediated by AMPK/Nrf2/Keap1-dependent inhibition of cellular senescence, suggesting a potential therapeutic strategy for ALD.

本文使用的Yeasen产品

购物车
客服
转染试用